Clinical Trials Browser

Prostatic Neoplasms × atezolizumab × 90 days × Clear all

Prostatic Neoplasms

NCT05000294 2026-02-18

Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types

BreastEndocrineGastrointestinalGenitourinaryGynecologicNETSarcoma

Bile Duct Neoplasms, Breast Neoplasms, Gallbladder Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Vulvar Neoplasms, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

Clinical Trials

Abemaciclib With or Without Atezolizumab for mCRPC

Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types